The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Corporationusrenalcare.comSince 2026-03-17
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
R1 Therapeutics, Inc. A biopharmaceutical company focused on developing therapies for kidney disease | Series A Verified against 1 of 7 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $77.5M | 2026-03-17 | [ PART ] |